US 6011001
Method of protein therapy by orally administering crosslinked protein crystals
expired A61KA61K38/00
Quick answer
US patent 6011001 (Method of protein therapy by orally administering crosslinked protein crystals) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jan 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K38/00